Meet the Agents: Specialized AI for every stage of the Design-Build-Test-Discover cycle. Each agent executes real scientific algorithms, not just text generation. teselagen.com/tesela-ai
@teselagen.bsky.social
@teselagen.bsky.socialMeet the Agents: Specialized AI for every stage of the Design-Build-Test-Discover cycle. Each agent executes real scientific algorithms, not just text generation. teselagen.com/tesela-ai
@aspenbio.bsky.socialWhich San Diego biotechs are tackling cancer and expanding? Pharm2Market’s Biotech Hub brings you regional news, events, and venture capital trends. Perfect for founders, sales reps & job hunters! #Biotech #News #Intelligence 🌟
Got questions? Pharm2Market has the answers!
bit.ly/3UfeaSG
@markfortner.bsky.socialWhich San Diego biotechs are tackling cancer and expanding? Pharm2Market’s Biotech Hub brings you regional news, events, and venture capital trends. Perfect for founders, sales reps & job hunters! #Biotech #News #Intelligence 🌟
Got questions? Pharm2Market has the answers!
bit.ly/3UfeaSG
@drtimos.bsky.social🧠 Competitive Insights for #BioPharma and #HealthTech 🚀
#LucidQuest arms #pharma & #biotech with real-time intel to outpace rivals from R&D to market.
📩 [email protected] or http://dlvr.it/TVxXLr
#CompetitiveIntelligence #Strategy #MarketAccess
@aktiego.bsky.socialCaribou Biosciences says its CAR-T data held up. The funding didn't. Both programs are now shut down.
Read more: aktiego.com/sectors/biot...
Full Disclaimer: aktiego.com/disclaimer/
#Biotech #CellTherapy
@quartzmedia.bsky.social@markfortner.bsky.socialVerastem’s KRAS inhibitor shows promise in pancreatic cancer |#biotech #biotechsky #cancer #PancreaticCancer www.statnews.com/2026/10/15/b...
@pharmalot.bsky.social@pharmalot.bsky.social
@cbgstudio.bsky.social[ALERT] A new active intrusion specimen has been extruded into the manifold: UNVERIFIED SPECIMEN: 6ad220a531a3bfb8b109735b
@nexthorizonspace.bsky.social
@forbes.itCon 18 miliardi investiti in accordi e una spesa record in ricerca, Dave Ricks prepara Eli Lilly al dopo GLP-1 puntando su #Alzheimer, sonno e nuove terapie #acquisizioni #biotech #brevetti #dave-ricks #disturbi-del-sonno #eli-lilly #glp-1 #industria-farmaceutica #intelligenza-artificia...
@elixstocksdata.bsky.socialBiotech catalysts today (Fri Oct 16)
$TECX presents at ADA
Dates from the companies' SEC filings
#Biotech #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
@drtimos.bsky.socialSignal or noise? > Jyong Biotech Announces Proposed Texas Facility to Support
Potential Commercialization of Its Drug Candidates - Yahoo
Finance >> Comment below! #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #healthcare #pharma #pharmaceutical
@4040rec.bsky.social
@drtimos.bsky.social🚀 #DigitalHealth | #AI | #IoE 🌐
At #LucidQuest, we turn bold ideas into patient-centric, AI-powered solutions for #Pharma, #Biotech & #HealthTech.
Let’s shape the future of care together.
📩 [email protected] or
@thedailyfathom.bsky.socialBIOTECH · AstraZeneca pays insitro $40M for AI drug deal
The deal could reach $1.5 billion as insitro's AI hunts for new drug targets in liver and heart disease.
@crvscience-news.bsky.socialMysterious brain activity under anesthesia challenges what we know about consciousness
www.sciencedaily.com/releases/202...
#Science #Neuroscience #Biology #Biotech #BioScience #SciNews
@biotechstockdaily.bsky.social
@bold-asx.bsky.socialDIMERIX LIMITED (ASX: DXB) The first 100 patients have completed two years of blinded treatment in Dimerix’s ACTION3 Phase 3 trial. #ASX #Biotech
boldinvestors.com.au/news/dimerix...